Oritavancin + Drugs Metabolized By Cyp2d6 Interaction
Moderateinteraction on record
Description
ORBACTIV is a weak inhibitor of CYP2C9. Co-administration may increase or decrease concentrations; close monitoring for toxicity or lack of efficacy is advised.
Mechanism
CYP2C9 inhibition
Source: NLP:oritavancin